MAXVAX
Latest round
- Series D
Last raised
- Dec 2025
Total raised
- $159M
Investors
- 19
About MAXVAX
, dba Maxhealth or MAXVAX, is a biotechnology company that focuses on the development of vaccines, and adjuvants. Dr. Dexiang Chen, the company's founder, has worked in Wyeth, Novartis, and PATH international public health agencies, and has 30 years of vaccine development experience. The R&D centers have been set up in Shanghai, Chengdu, and Hangzhou, and it has a production base in Shanghai Lingang New Area. The company has acquired certifications such as Specialized, Refined, Featured, and Original SMEs and the national high-tech enterprise. The company is engaged in the research, development, production, marketing, and sale of a new influenza vaccine, a new rabies vaccine, a new rotavirus vaccine, and a new shingles vaccine for the elderly. Its self-developed biotechnology platforms include an adjuvant technology platform, a recombinant protein platform, and an mRNA technology platform. The company generates revenue by providing vaccines and immunotherapies. The company will use the venture debt for the research and development of adjuvant platforms, construction of adjuvant workshops, vaccine clinical trials, preclinical research and development of vaccine pipelines, and international cooperation.
Who invested in MAXVAX
19 investors across 8 rounds
See all investors in MAXVAX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Dec 25, 2025
Amount
Undisclosed
Investors
Series D
Oct 31, 2025
Amount
Undisclosed
Investors
Series C
Jun 10, 2024
Amount
Undisclosed
Investors
Series C
Feb 6, 2024
Amount
$42M
Investors
Series B
Dec 7, 2022
Amount
$43M
Investors
Series B
Jul 20, 2022
Amount
$74M
Investors
Series A
Jul 21, 2021
Amount
Undisclosed
Investors
Angel
Dec 19, 2017
Amount
Undisclosed
Investors
Questions about MAXVAX
Who invested in MAXVAX?
MAXVAX has 19 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MAXVAX raised?
MAXVAX has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did MAXVAX last raise money?
MAXVAX's most recent round on record is a Series D, in Dec 2025.
What does MAXVAX do?
, dba Maxhealth or MAXVAX, is a biotechnology company that focuses on the development of vaccines, and adjuvants.
Where is MAXVAX headquartered?
MAXVAX is headquartered in Chengdu, China.
Which VCs invest in companies like MAXVAX?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MAXVAX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like MAXVAX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.